INT21933

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.28
First Reported 1986
Last Reported 2010
Negated 3
Speculated 0
Reported most in Abstract
Documents 5
Total Number 5
Disease Relevance 5.48
Pain Relevance 5.29

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

plasma membrane (Pag1) intracellular (Pag1)
Anatomy Link Frequency
LRF 2
PAG 2
Pag1 (Mus musculus)
Pain Link Frequency Relevance Heat
Central grey 34 100.00 Very High Very High Very High
Periaqueductal grey 19 100.00 Very High Very High Very High
GABAergic 4 100.00 Very High Very High Very High
Opioid 6 99.98 Very High Very High Very High
Spinal cord 1 99.56 Very High Very High Very High
Antinociceptive 5 99.48 Very High Very High Very High
narcan 6 99.40 Very High Very High Very High
agonist 4 98.20 Very High Very High Very High
Neurotransmitter 2 96.68 Very High Very High Very High
Morphine 1 96.36 Very High Very High Very High
Disease Link Frequency Relevance Heat
Urological Neuroanatomy 53 100.00 Very High Very High Very High
Bradycardia 4 100.00 Very High Very High Very High
Spinal Cord Injury 1 99.56 Very High Very High Very High
Diabetes Mellitus 10 98.68 Very High Very High Very High
Hyperalgesia 4 91.52 High High
Peripheral Arterial Disease 1 89.76 High High
Pressure Volume 2 Under Development 3 88.52 High High
Nociception 1 75.00 Quite High
Pain 1 51.88 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Systemic methysergide (2-6 mg/kg i.v.) selectively reduced PAG-evoked inhibition in 6 units, while inhibitions from both PAG and LRF stimulation were reduced in one unit and unaffected in 8 units.
Neg (unaffected) Regulation (unaffected) of Negative_regulation (inhibitions) of PAG in LRF associated with central grey
1) Confidence 0.28 Published 1990 Journal Brain Res. Section Abstract Doc Link 2224516 Disease Relevance 0.78 Pain Relevance 0.98
PAG inhibition of baroreflex vagal bradycardia was not affected following spinal cord transection at C1, indicating that the inhibition was exclusively central in origin and not due to peripheral, prejunctional inhibition of vagal acetylcholine release by increased cardiac sympathetic nerve activities.
Neg (not) Regulation (affected) of Negative_regulation (inhibition) of PAG in PAG associated with periaqueductal grey, bradycardia and spinal cord
2) Confidence 0.22 Published 1993 Journal Pflugers Arch. Section Abstract Doc Link 8414916 Disease Relevance 1.58 Pain Relevance 0.61
In contrast, PAG/NRD stimulation-produced inhibition of the VIR was unaffected by intravenous naloxone.
Neg (unaffected) Regulation (unaffected) of Negative_regulation (inhibition) of PAG associated with narcan and central grey
3) Confidence 0.20 Published 1986 Journal Brain Res. Section Abstract Doc Link 3697757 Disease Relevance 0.85 Pain Relevance 0.66
Here we report that opioid inhibition of GABAergic synaptic currents in the PAG is controlled by a presynaptic voltage-dependent potassium conductance.
Regulation (controlled) of Negative_regulation (inhibition) of PAG associated with periaqueductal grey, gabaergic and opioid
4) Confidence 0.17 Published 1997 Journal Nature Section Abstract Doc Link 9403690 Disease Relevance 0.43 Pain Relevance 1.62
It is concluded that down-regulation of TRPV1 receptors in PAG is responsible for reduced antinociceptive effect of TRPV1 agonist.
Regulation (responsible) of Negative_regulation (regulation) of PAG associated with agonist, antinociceptive and central grey
5) Confidence 0.01 Published 2010 Journal Brain Res. Section Abstract Doc Link 20211611 Disease Relevance 1.84 Pain Relevance 1.42

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox